Valsartan/hydrochlorothiazide 80/12.5 mg film-coated tablets – patient leaflet, side effects, dosage

1. What Valsartan/Hydrochlorothiazide film-coated tablets are and what they are used for

Valsartan/Hydrochlorothiazide film-coated tablets contain two active substances called valsartan and hydrochlorothiazide. Both of these substances help to control high blood pressure (hypertension).

• Valsartan belongs to a class of medicines known as “angiotensin II receptor

  antagonists”, which help to control high blood pressure. Angiotensin II is a substance in the body that causes vessels to tighten, thus causing your blood pressure to increase. Valsartan works by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered.

• Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics

  (also known as “water tablets”). Hydrochlorothiazide increases urine output, which also lowers blood pressure.

This medicine is used to treat high blood pressure which is not adequately controlled by a single substance alone.

High blood pressure increases the workload of the heart and arteries. If not treated, it can damage the blood vessels of the brain, heart, and kidneys, and may result in a stroke, heart failure or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure to normal reduces the risk of developing these disorders.

2. What you need to know before you take Valsartan/Hydrochlorothiazide film-coated tablets

Do not take Valsartan/Hydrochlorothiazide film-coated tablets:

• if you are allergic (hypersensitive) to valsartan, hydrochlorothiazide, sulphonamide

  derivatives (substances chemically related to hydrochlorothiazide) or to any of the other ingredients of this medicine (listed in section 6).

• if you are more than 3 months pregnant (it is also better to avoid this medicine

  in early pregnancy – see pregnancy section).

• if you have severe liver disease, destruction of the small bile ducts within the liver

  (biliary cirrhosis) leading to the build up of bile in the liver (cholestasis).

• if you have severe kidney disease.
• if you are unable to produce urine (anuria).
• if you are treated with an artificial kidney.

• if the level of potassium or sodium in your blood is lower than normal, or if the

  level of calcium in your blood is higher than normal despite treatment.

• if you have gout.

• if you have diabetes or impaired kidney function and you are treated with a blood

  pressure lowering medicine containing aliskiren.

If any of the above applies to you, do not take this medicine and speak to your doctor.

Warnings and precautions

Talk to your doctor or pharmacist before taking this medicine

• if you are taking potassium-sparing medicines, potassium supplements, salt

  substitutes containing potassium or other medicines that increase the amount of potassium in your blood such as heparin. Your doctor may need to check the amount of potassium in your blood regularly.

• if you have low levels of potassium in your blood.

• if you have experience abdominal pain, nausea, vomiting or diarrhoea after taking

  Valsartan/Hydrochlorothiazide film-coated tablets. Your doctor will decide on further treatment. Do not stop taking Valsartan/Hydrochlorothiazide film-coated tablets on your own.

• if you are taking high doses of water tablets (diuretics).
• if you have severe heart disease.

• if you are suffering from heart failure or have experienced a heart attack. Follow

  your doctor’s instruction for the starting dose carefully. Your doctor may also check your kidney function.

• if you suffer from a narrowing of the kidney artery.
• if you have recently received a new kidney.

• if you suffer from hyperaldosteronism. This is a disease in which your adrenal

  glands make too much of the hormone aldosterone. If this applies to you, the use of Valsartan/Hydrochlorothiazide film-coated tablets is not recommended.

• if you have liver or kidney disease.

• if you have ever experienced swelling of the tongue and face caused by an

  allergic reaction called angioedema when taking another drug (including ACE inhibitors), tell your doctor. If these symptoms occur when you are taking Valsartan/Hydrochlorothiazide film-coated tablets, stop taking Valsartan/ Hydrochlorothiazide film-coated tablets immediately and never take it again. See also section 4, “Possible side effects”.

• if you have fever, rash and joint pain, which may be signs of systemic lupus

  erythematosus (SLE, a so-called autoimmune disease).

• if you have diabetes, gout, high levels of cholesterol or triglycerides in your blood.

• if you have had allergic reactions with the use of other blood pressure-lowering

  agents of this class (angiotensin II receptor antagonists) or if you have allergy or asthma.

• if you experience a decrease in vision or eye pain. These could be symptoms

  of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to a week of taking Valsartan/Hydrochlorothiazide film-coated tablets. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulphonamide allergy you can be at higher risk of developing this.

• it may cause increased sensitivity of the skin to sun.

• if you are taking any of the following medicines used to treat high blood pressure:

  • an ACE inhibitor (for example enalapril, lisinopril, ramipril), in particular if

    you have diabetes-related kidney problems.

  • Aliskiren.

• if you have had skin cancer or if you develop an unexpected skin lesion during

  the treatment. Treatment with hydrochlorothiazide, particularly long term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Valsartan/Hydrochlorothiazide film-coated tablets

• If you experienced breathing or lung problems (including inflammation or fluid

  in the lungs) following hydrochlorothiazide intake in the past. If you develop any severe shortness of breath or difficulty breathing after taking Valsartan/ Hydrochlorothiazide film-coated tablets, seek medical attention immediately. Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.

  See also information under the heading “Do not take Valsartan/Hydrochlorothiazide film-coated tablets”.

  You must tell your doctor if you think you are (or might become) pregnant. Valsartan/ Hydrochlorothiazide film-coated tablets are not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

  Children and adolescents

  The use of this medicine in children and adolescents (below the age of 18 years) is not recommended.

  Other medicines and Valsartan/Hydrochlorothiazide film-coated tablets

  Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

  The effect of the treatment can be influenced if Valsartan/Hydrochlorothiazide film-coated tablets are taken together with certain other medicines. Your doctor may need to change your dose and/or to take other precautions. This especially applies to the following medicines:

  • lithium, a medicine used to treat some types of psychiatric diseases.

  • medicines or substances that may increase the amount of potassium in your blood.

    These include potassium supplements or salt substitutes containing potassium, potassium-sparing medicines and heparin.

  • medicines that may reduce the amount of potassium in your blood, such as diuretics (water tablets), corticosteroids, laxatives, carbenoxolone, amphotericin or penicillin G.
  • some antibiotics (rifamycin group), a drug used to protect against transplant rejection (ciclosporin) or an antiretroviral drug used to treat HIV/AIDS infection (ritonavir). These drugs may increase the effect of Valsartan/Hydrochlorothiazide film-coated tablets.
  • medicines that may induce “torsades de pointes” (irregular heart beat), such as antiarrhythmics (medicines used to treat heart problems) and some antipsychotics.
  • medicines that may reduce the amount of sodium in your blood, such as antidepressants, antipsychotics, antiepileptics.
  • medicines for the treatment of gout, such as allopurinol, probenecid, sulfinpyrazone, therapeutic vitamin D and calcium supplements.
  • medicines for the treatment of diabetes (oral agents such as metformin or insulins).
  • other medicines to lower your blood pressure, including methyldopa, ACE inhibitors (such as enalapril, lisinopril, etc.) .) or aliskiren (see also information under the headings “Do not take Valsartan/Hydrochlorothiazide film-coated tablets” and “Warnings and precautions”).
  • medicines to increase blood pressure, such as noradrenaline or adrenaline.
  • digoxin or other digitalis glycosides (medicines used to treat heart problems).
  • medicines that may increase blood sugar levels, such as diazoxide or beta blockers.
  • cytotoxic medicines (used to treat cancer) such as methotrexate or cyclophosphamide.
  • pain killers such as non-steroidal anti-inflammatory agents (NSAIDs), including selective cyclooxygenase-2 inhibitors (Cox-2 inhibitors) and acetylsalicylic acid > 3 g.
  • muscle relaxing medicines, such as tubocurarine.
  • anti-cholinergic medicines (medicines used to treat a variety of disorders such as gastrointestinal cramps, urinary bladder spasm, asthma, motion sickness, muscular spasms, Parkinson’s disease and as an aid to anaesthesia).
  • amantadine (medicine used to treat Parkinson’s disease and also used to treat or prevent certain illnesses caused by viruses).
  • cholestyramine and colestipol (medicines used mainly to treat high levels of lipids in the blood).
  • ciclosporin, a medicine used for organ transplant to avoid organ rejection.
  • alcohol, sleeping pills and anaesthetics (medicines with sleeping or painkilling effect used for example during surgery).
  • iodine contrast media (agents used for imaging examinations).

Valsartan/Hydrochlorothiazide film-coated tablets with drink and alcohol

Avoid taking alcohol until you have talked to your doctor. Alcohol may make your blood pressure fall more and/or increase the risk of you becoming dizzy or feeling faint.

Pregnancy and breast-feeding

• You must tell your doctor if you think that you are (or might become)

  pregnant

Your doctor will normally advise you to stop taking this medicine before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Valsartan/Hydrochlorothiazide film-coated tablets. This medicine is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if it is used after the third month of pregnancy.

• Tell your doctor if you are breast-feeding or about to start breast-feeding Valsartan/Hydrochlorothiazide film-coated tablets are not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.

Driving and using machines

Before you drive a vehicle, use tools or operate machines or carry out other activities that require concentration, make sure you know how this medicine affects you. Like many other medicines used to treat high blood pressure, Valsartan/ Hydrochlorothiazide film-coated tablets may occasionally cause dizziness and affect the ability to concentrate.

Valsartan/Hydrochlorothiazide film-coated tablets contain lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. How to take Valsartan/Hydrochlorothiazide film-coated tablets

Always take this medicine exactly as your doctor has told you. This will help you to get the best results and lower the risk of side effects. Check with your doctor or pharmacist if you are not sure.

People with high blood pressure often do not notice any signs of this problem. Many may feel quite normal. This makes it all the more important for you to keep your appointments with your doctor even if you are feeling well.

Your doctor will tell you exactly how many tablets of Valsartan/Hydrochlorothiazide to take. Depending on how you respond to the treatment, your doctor may suggest a higher or lower dose.

• The usual dose of Valsartan/Hydrochlorothiazide is one tablet per day.
• Do not change the dose or stop taking the tablets without consulting your doctor.
• The medicine should be taken at the same time each day, usually in the morning.
• You can take Valsartan/Hydrochlorothiazide film-coated tablets with or without food.
• Swallow the tablet with a glass of water.

If you take more Valsartan/Hydrochlorothiazide film-coated tablets than you should

If you experience severe dizziness and/or fainting, lie down and contact your doctor immediately.

If you have accidentally taken too many tablets, contact your doctor, pharmacist or hospital.

If you forget to take Valsartan/Hydrochlorothiazide film-coated tablets

If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the dose you missed.

Do not take a double dose to make up for a forgotten dose.

If you stop taking Valsartan/Hydrochlorothiazide film-coated tablets

Stopping your treatment with Valsartan/Hydrochlorothiazide film-coated tablets may cause your high blood pressure to get worse. Do not stop taking your medicine unless your doctor tells you to.

--

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects can be serious and need immediate medical attention:

You should see your doctor immediately if you experience symptoms of angioedema, such as:

• swollen face, tongue or pharynx
• difficulty in swallowing
• hives and difficulties in breathing

• Severe skin disease that causes rash, red skin, blistering of the lips, eyes or mouth,

  skin peeling, fever (toxic epidermal necrolysis).

• Decrease in vision or pain in your eyes due to high pressure (possible signs of

  fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma).

• Fever, sore throat, more frequent infections (agranulocytosis). • Severe shortness of breath, fever, weakness, and confusion (acute respiratory

  distress syndrome).

• Intestinal angioedema: a swelling in the gut presenting with symptoms like

  abdominal pain, nausea, vomiting and diarrhoea

These side effects are very rare or of frequency not known

If you get any of these symptoms, stop taking Valsasrtan/Hydrochlorothiazide Jubilant and contact your doctor straight away (see also section 2 “Take special care with Valsasrtan/Hydrochlorothiazide Jubilant”).

Other side effects of Valsartan/Hydrochlorothiazide film-coated tablets include:

Uncommon (may affect up to 1 in 100 people)

• cough
• low blood pressure
• light-headedness

• dehydration (with symptoms of thirst, dry mouth and tongue, infrequent urination,

  dark colored urine, dry skin)

• muscle pain
• tiredness
• tingling or numbness
• blurred vision
• noises (e.g. hissing, buzzing) in ears

Very rare (may affect up to 1 in 10000 people)

• dizziness
• diarrhoea
• joint pain

Not known (frequency cannot be estimated from the available data) • breathing difficulty

• severely decreased urine output

• low level of sodium in the blood (which can trigger tiredness, confusion, muscle

  twitching and/or convulsions in severe cases)

• low level of potassium in the blood (sometimes with muscle weakness, muscle

  spasms, abnormal heart rhythm)

• low level of white cells in the blood (with symptoms such as fever, skin infections,

  sore throat or mouth ulcers due to infections, weakness)

• the level of bilirubin increased in blood (which can, in severe cases, trigger yellow

  skin and eyes)

• the level of blood urea nitrogen and creatinine increased in blood (which can

  indicate abnormal kidney function)

• the level of uric acid in blood increased (which can, in severe cases, trigger gout) • syncope (fainting)

Side effects reported with valsartan or hydrochlorothiazide alone:

Valsartan

Uncommon (may affect up to 1 in 100 people)

• spinning sensation
• abdominal pain

Very rare

• Intestinal angioedema: a swelling in the gut presenting with symptoms like

  abdominal pain, nausea, vomiting and diarrhoea

Not known (frequency cannot be estimated from the available data) • blistering skin (sign of dermatitis bullous)

• skin rash with or without itching together with some of the following signs or

  symptoms: fever, joint pain, muscle pain, swollen lymph nodes and/or flu-like symptoms

• rash, purplish-red spots, fever, itching (symptoms of inflammation of blood

  vessels)

• low level of blood platelets (sometimes with unusual bleeding or bruising) • high level of potassium in the blood (sometimes with muscle spasms, abnormal

  heart rhythm)

• allergic reactions (with symptoms such as rash, itching, hives, difficulty in

  breathing or swallowing, dizziness)

• swelling mainly of the face and throat; rash; itching
• elevation of liver function values

• the level of haemoglobin decreased and the percentage of red cells decreased in

  the blood (which both can, in severe cases, trigger an anaemia). • kidney failure

• low level of sodium in the blood (which can trigger tiredness, confusion, muscle

  twitching and/or convulsions in severe cases)

Hydrochlorothiazide

Very common (may affect more than 1 in 10 people)

• low level of potassium in the blood
• increase of lipids in the blood

Common (may affect up to 1 in 10 people)

• low level of sodium in the blood
• low level of magnesium in the blood
• high level of uric acid in the blood
• itchy rash and other types of rash
• reduced appetite
• mild nausea and vomiting
• dizziness, fainting on standing up
• inability to achieve or maintain erection

Rare (may affect up to 1 in 1000 people)

• swelling and blistering of the skin (due to increased sensitivity to sun) • high level of calcium in the blood
• high level of sugar in the blood
• sugar in the urine
• worsening of diabetic metabolic state

• constipation, diarrhoea, discomfort of the stomach or bowels, liver disorders

  which can occur together with yellow skin and eyes

• irregular heart beat
• headache
• sleep disturbances
• sad mood (depression)

• low level of blood platelets (sometimes with bleeding or bruising underneath the

  skin)

• dizziness
• tingling or numbness

• vision disorder

  Very rare (may affect up to 1 in 10000 people)

  • inflammation of blood vessels with symptoms such as rash, purplish-red spots, fever (vasculitis)
  • rash, itching, hives, difficulty in breathing or swallowing, dizziness (hypersensitivity reactions)
  • facial rash, joint pain, muscle disorder, fever (lupus erythematosus) • severe upper stomach pain (pancreatitis)
  • difficulty breathing with fever, coughing, wheezing, breathlessness (respiratory distress including pneumonitis and pulmonary oedema)
  • fever, sore throat, more frequent infections (agranulocytosis) • pale skin, tiredness, breathlessness, dark urine (haemolytic anaemia) • fever, sore throat or mouth ulcers due to infections (leucopenia) • confusion, tiredness, muscle twitching and spasm, rapid breathing (hypochloraemic alkalosis)

Not known (frequency cannot be estimated from the available data) • weakness, bruising and frequent infections (aplastic anemia)

• severely decreased urine output (possible signs of renal disorder or renal failure) • rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever (possible signs of erythema multiforme)
• muscle spasm
• fever (pyrexia)
• weakness (asthenia)
• skin and lip cancer (Non-melanoma skin cancer)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (website: www.mhra.gov.uk/yellowcard). By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Valsartan/Hydrochlorothiazide film-coated tablets

• Keep this medicine out of the sight and reach of children.

• Do not use this medicine after the expiry date which is stated on the pack after

  EXP. The expiry date refers to the last day of that month.

• Store below 25 °C.
• Do not use any Valsartan/Hydrochlorothiazide film-coated tablets pack if you notice that it is damaged or shows signs of tampering.
• Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information What Valsartan/Hydrochlorothiazide film-coated tablets contain

• The active substances are valsartan and hydrochlorothiazide.

  Valsartan/Hydrochlorothiazide 80/12.5 mg film-coated tablets: Each tablet contains 80 mg valsartan and 12.5 mg hydrochlorothiazide Valsartan/Hydrochlorothiazide 160/25 mg film-coated tablets: Each tablet contains 160 mg valsartan and 25 mg hydrochlorothiazide

• The other ingredients are:

  tablet core

  Cellulose, microcrystalline (E460), crospovidone (E1202), silica, magnesium stearate (E470b) and anhydrous lactose.

  tablet coating

  Valsartan/Hydrochlorothiazide 80/12.5 mg film-coated tablets: Hypromellose (E464), titanium dioxide (E171), macrogol, iron oxide yellow (E172), iron oxide red (E172) and talc.

  Valsartan/Hydrochlorothiazide 160/25 mg film-coated tablets: Hypromellose (E464), titanium dioxide (E171), macrogol, iron oxide yellow (E172), iron oxide black (E172), iron oxide red (E172) and talc.

What Valsartan/Hydrochlorothiazide film-coated tablets look like and contents of the pack

Valsartan/Hydrochlorothiazide 80/12.5 mg film-coated tablets are peach coloured, oval shaped, biconvex, film-coated tablets debossed with ‘364’ on one side and ‘J’ on the other side.

Valsartan/Hydrochlorothiazide 160/25 mg film-coated tablets are brown coloured, oval shaped, biconvex, film-coated tablets debossed with ‘366’ on one side and ‘J’ on the other side.

The tablets are available in blister packs of 14, 20, 28, 30, 56, 60, 90, 98 or 100 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Jubilant Pharma UK Limited

Office 14, Bizspace Ashford,

The Cobalt Building, 1600 Eureka Park,

Lower Pemberton Kennington, Ashford,

TN25 4BF, United Kingdom

Manufacturer

PSI Supply NV

Axxes Business Park

Guldensporenpark 22 – Block C

9820 Merelbeke

Belgium

Elara Pharmaservices Limited

5 Garden Court, Lockington Hall

Main Street, Lockington, Derby

DE74 2RH, United Kingdon

Jubilant Pharma UK Limited

Office 14, Bizspace Ashford,

The Cobalt Building, 1600 Eureka Park,

Lower Pemberton Kennington, Ashford,

TN25 4BF, United Kingdom

This medicinal product is authorized in the Member States of the EEA under the following names:

Valsartan/Hydrochlorothiazide Jubilant 80 mg/12.5 mg film-coated tablets Denmark Valsartan/Hydroklortiazid Jubilant 80 mg/12,5 mg filmovertrukne tabletter Germany Valsartan/Hydrochlorothiazid Jubilant 80 mg/12,5 mg

Filmtabletten

The Netherlands Valsartan/HCT Jubilant 80 mg/12,5 mg filmomhulde tabletten Sweden Valsartan/Hydroklortiazid Jubilant 80 mg/12,5 mg filmdragerade tabletter

United Kingdom Valsartan/Hydrochlorothiazide 80/12.5 mg film-coated tablets

Valsartan/Hydrochlorothiazide Jubilant 160 mg/25 mg film-coated tablets Denmark Valsartan/Hydroklortiazid Jubilant 160 mg/25 mg filmovertrukne tabletter

Germany Valsartan/Hydrochlorothiazid Jubilant 160 mg/25 mg

Filmtabletten

The Netherlands Valsartan/HCT Jubilant 160 mg/25 mg filmomhulde tabletten Sweden Valsartan/Hydroklortiazid Jubilant 160 mg/25 mg filmdragerade tabletter

United Kingdom Valsartan/Hydrochlorothiazide 160/25 mg film-coated tablets

This leaflet was last revised in January 2026.

--